DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Cursiefen C, Bock F, Horn FK. et al.
GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial.
Ophthalmology 2009;
116: 1630-1637
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.